ATR INHIBITORS IN COMBINATION WITH RADIATION AND TEMOZOLOMIDE INCREASE CELL DEATH OF PATIENT-DERIVED GLIOBLASTOMA CELLS

被引：0
|
作者：
Lozinski, Mathew [1 ,2 ]
Bowden, Nikola [3 ]
Fay, Michael [2 ,4 ]
Graves, Moira [1 ,5 ]
Day, Bryan [6 ]
Stringer, Brett [7 ]
Tooney, Paul [1 ,2 ]
机构：
[1] Univ Newcastle, Callaghan, Australia
[2] Mark Hughes Fdn Ctr Brain Canc Res, Callaghan, Australia
[3] Hunter Med Res Inst, Drug Repurposing & Med Res Program, New Lambton Hts, Australia
[4] GenesisCare, Newcastle, Australia
[5] Hunter Med Res Inst, Drug Repurposing & Med Res Program, Callaghan, Australia
[6] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[7] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Australia
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0458
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NOAE165.04
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) AND TEMOZOLOMIDE IN MGMT EXPRESSING AND NON-EXPRESSING PATIENT-DERIVED GLIOBLASTOMA CELLS
    Clark, Paul
    Gaal, Jordan
    Pasch, Cheri
    Strebe, Joslyn
    Deming, Dustin
    Kuo, John
    Robins, H. Ian
    NEURO-ONCOLOGY, 2016, 18 : 64 - 64
  • [22] CHARACTERIZATION OF PATIENT-DERIVED PRIMARY CELL LINES AND XENOGRAFTS FOR GLIOBLASTOMA
    Kijima, Noriyuki
    Kanematsu, Daisuke
    Shofuda, Tomoko
    Nonaka, Masahiro
    Iwata, Ryoichi
    Fukai, Junya
    Inoue, Akihiro
    Sasayama, Takashi
    Tsuyuguchi, Naohiro
    Kawashima, Toshiyuki
    Higuchi, Yuichiro
    Suemizu, Hiroshi
    Mori, Kanji
    Kishima, Haruhiko
    Kanemura, Yonehiro
    NEURO-ONCOLOGY, 2019, 21 : 262 - 262
  • [23] A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
    Johansson, Patrik
    Krona, Cecilia
    Kundu, Soumi
    Doroszko, Milena
    Baskaran, Sathishkumar
    Schmidt, Linnea
    Vinel, Claire
    Almstedt, Elin
    Elgendy, Ramy
    Elfineh, Ludmila
    Gallant, Caroline
    Lundsten, Sara
    Gago, Fernando J. Ferrer
    Hakkarainen, Aleksi
    Sipila, Petra
    Haggblad, Maria
    Martens, Ulf
    Lundgren, Bo
    Frigault, Melanie M.
    Lane, David P.
    Swartling, Fredrik J.
    Uhrbom, Lene
    Nestor, Marika
    Marino, Silvia
    Nelander, Sven
    CELL REPORTS, 2020, 32 (02):
  • [24] RADIOSENSITIZING EFFECTS OF HDAC INHIBITORS AND RESPONSE PROFILING IN PATIENT-DERIVED GLIOBLASTOMA CULTURES
    Pont, L. M. E. Berghauser
    Kloezeman, J. J.
    French, P. J.
    Dirven, C. M. F.
    Lamfers, M. L. M.
    Leenstra, S. L.
    NEURO-ONCOLOGY, 2012, 14 : 53 - 53
  • [25] Temozolomide-Resistant Glioma Cells Are Sensitive to Chloroethylating Nitrosourea Compounds in Combination with ATR Inhibitors
    Jackson, C.
    Kalathil, A. N.
    Sundaram, R. K.
    Bindra, R. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E639 - E639
  • [26] TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS
    Jackson, Christopher
    Kalathil, Aravind
    Bindra, Ranjit
    NEURO-ONCOLOGY, 2019, 21 : 94 - 94
  • [27] Differential response of patient-derived primary glioblastoma cells to environmental stiffness
    Grundy, Thomas James
    De Leon, Ellen
    Griffin, Kaitlyn Rose
    Stringer, Brett William
    Day, Bryan William
    Fabry, Ben
    Cooper-White, Justin
    O'Neill, Geraldine Margaret
    SCIENTIFIC REPORTS, 2016, 6
  • [28] GENERATION AND EVALUATION OF ORGANOID CULTURES FROM PATIENT-DERIVED GLIOBLASTOMA CELLS
    Ojeda, Alejandra Velazquez
    Brewster, Blake
    Brown, Christine
    Barish, Michael
    NEURO-ONCOLOGY, 2017, 19 : 264 - 264
  • [29] Differential response of patient-derived primary glioblastoma cells to environmental stiffness
    Thomas James Grundy
    Ellen De Leon
    Kaitlyn Rose Griffin
    Brett William Stringer
    Bryan William Day
    Ben Fabry
    Justin Cooper-White
    Geraldine Margaret O’Neill
    Scientific Reports, 6
  • [30] Heterogeneous invasion capacity of patient-derived primary glioblastoma multiforme cells
    Schrickel, F.
    Wank, M.
    Meyer, B.
    Gempt, J.
    Barz, M.
    Thomsen, A. R.
    Schmid, T. E.
    Combs, S. E.
    Schilling, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S109 - S110
12345